Vermillion Inc. (NASDAQ:VRML) was the target of a large decrease in short interest in October. As of October 31st, there was short interest totalling 251,861 shares, a decrease of 53.1% from the October 14th total of 536,587 shares. Based on an average trading volume of 73,027 shares, the short-interest ratio is currently 3.4 days. Currently, 0.8% of the shares of the stock are short sold.

Shares of Vermillion (NASDAQ:VRML) opened at 1.2431 on Friday. The stock’s 50 day moving average price is $1.13 and its 200 day moving average price is $1.23. Vermillion has a one year low of $0.76 and a one year high of $2.00. The stock’s market capitalization is $64.92 million.

Vermillion (NASDAQ:VRML) last announced its quarterly earnings data on Thursday, November 10th. The company reported ($0.07) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.06) by $0.01. Vermillion had a negative net margin of 778.21% and a negative return on equity of 128.58%. Equities research analysts predict that Vermillion will post ($0.29) EPS for the current fiscal year.

About Vermillion

Vermillion, Inc is a diagnostic service and bio-analytic solutions provider. The Company is engaged in the business of developing and commercializing diagnostic tests for gynecologic disease. It sells OVA1 risk of malignancy test for pelvic mass disease (OVA1). OVA1 is a blood test designed to, in addition to a physician’s clinical assessment of a woman with a pelvic mass, identify women who are at risk of having a malignant ovarian tumor prior to planned surgery.

5 Day Chart for NASDAQ:VRML

Receive News & Stock Ratings for Vermillion Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vermillion Inc. and related stocks with our FREE daily email newsletter.